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Giving children the best possible start in life is crucial to 
reduce health disparities.1 One of the UK Government’s 
eﬀ orts to support young children has been to adapt and 
assess the Family Nurse Partnership (FNP), a programme 
of prenatal and early childhood home visiting for 
vulnerable ﬁ rst-time mothers and their children. In 
The Lancet, Michael Robling and colleagues2 report on 
Building Blocks, a multisite trial of the FNP in England. 
My colleagues and I3,4 have developed and tested this 
programme previously in three randomised trials in 
the USA. We made independent randomised trials a 
prerequisite for international expansion when serving 
large populations, because knowing a programme’s 
added value in new contexts is essential for guiding 
policy and practice.
In Robling and colleagues’ pragmatic, open, individually 
randomised, controlled trial,2 1645 participants in 
community midwifery settings at 18 sites in England 
were randomly assigned to the FNP programme 
(823 participants received up to 64 structured home 
visits from early pregnancy until the child’s second 
birthday, delivered by specially recruited and trained 
family nurses) added to usual care, and 822 received 
usual care alone. The Building Blocks trial is very well 
conducted, with objective measures, acceptable rates of 
completed assessments for most outcomes, and rigorous 
Building evidence to improve maternal and child health
Published Online
October 14, 2015
http://dx.doi.org/10.1016/
S0140-6736(15)00476-6
See Articles page 146
Liberia’s Ministry for Health and Social Welfare via the 
United States Agency for International Development. 
The Liberian armed forces and security sector stepped 
back their response after the West Point shooting of a 
civilian.8 The British military worked—in principle—under 
the direction of a civilian led by the UK’s Department 
for International Development, but integrated some 
personnel within the Sierra Leone armed forces. Although 
some militaries provided clinical care, others refused even 
to transport biological samples and patients.6
Some governments now indicate that they are prepared 
to revise their military doctrine, incorporating civil–military 
cooperation in health as a regular activity.9,10 However, the 
involvement of military personnel in such pursuits remains 
controversial and raises questions about their eﬀ ects 
on humanitarian principles, personnel, and practices.11,12 
Civil–military cooperation during the 2014 Ebola outbreak 
proved necessary and helped the aﬀ ected countries to 
contain the virus sooner, ultimately saving lives. But 
more evidence, analysis, and guidelines are needed about 
the types of health activities that military personnel can 
undertake in humanitarian crises before we witness, and 
need to respond to, another major disease outbreak.
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adherence to its statistical analysis plan; this strengthens 
the conclusion that FNP had no eﬀ ects compared with 
usual care on the study’s primary outcomes: prenatal 
cigarette smoking at the end of pregnancy (304 [56%] of 
547 participants with FNP vs 306 [56%] of 545 with usual 
care), subsequent pregnancies (426 [66%] of 643 with 
FNP vs 427 [66%] of 646 with usual care), birthweight 
(mean birthweight 3217·4 g [SD 618·0] for 742 children 
with FNP vs 3197·5 g [SD 581·5] for 768 children with 
usual care), or at least one child emergency encounter 
or hospital admission at an accident and emergency 
department (587 [81%] of 725 children with FNP vs 
577 [77%] of 753 children with usual care).2 The study’s 
design would have been strengthened, however, had it 
been guided more completely by ﬁ ndings from previous 
trials.3–5 Moreover, its results need to be understood in the 
context of usual care after FNP was added to local services. 
I raise these issues to encourage a deeper conversation 
within scientiﬁ c and policy communities about how best 
to use scarce research resources aimed at improving the 
early health and development of vulnerable populations.
As Robling and colleagues note, US trials identiﬁ ed 
that programme beneﬁ ts, such as mothers’ use of cash-
assistance welfare, timing of subsequent pregnancies, 
veriﬁ ed reports of child maltreatment, injuries and 
ingestions, and language and cognitive development, 
were most pronounced in families living in concentrated 
disadvantage and, for children, those born to mothers 
who had few psychological resources to cope with 
adversity.3–5 The UK FNP has focused on young mothers 
(<20 years of age) because their children are at risk of 
compromised development,6 and maternal age makes it 
easy to identify who qualiﬁ es.7 However, young mothers 
vary substantially in the extent to which they have 
overlapping challenges, such as ﬁ nancial diﬃ  culties, 
depression, and substance misuse.6 Positive FNP eﬀ ects 
identiﬁ ed in a Dutch trial8,9 of 460 disadvantaged women 
on outcomes such as child maltreatment, children’s 
internalising behavioural problems, and intimate partner 
violence might be attributed, at least partly, to its serving 
highly vulnerable mothers, irrespective of their age. 
Robling and colleagues’ trial examined a set of possible 
moderators of FNP eﬀ ects, but it was not designed to 
estimate eﬀ ects with those most vulnerable.
Moreover, we need to consider what usual care was in 
Robling and colleagues’ study.2 How did eﬀ orts of teenage 
pregnancy midwives and health visitors aﬀ ect estimates 
of FNP’s added value? The usual-care group, for instance, 
received a mean of 16·25 (SD 12·15) visits by health 
visitors—a number probably even higher in those at risk. 
In view of the fact that health visitors in this trial were 
informed of mothers’ service assignments and directed 
not to visit families in FNP, the 8·6 (SD 13·74) mean 
number of health-visitor encounters reported by mothers 
in FNP must be interpreted with caution. FNP records 
show a mean of 39·28 (SD 15·19) FNP visits completed 
during pregnancy through to the age of 2 years; this 
represents excellent maternal engagement and is 
probably more than enough to help low-risk mothers.10
Additionally, FNP and usual-care eﬀ ects on prenatal 
smoking should be placed in the context of other smoking 
interventions. As noted in the supplementary materials,2 
women in FNP identiﬁ ed as smokers at registration quit 
at a rate of 17% (49 of 293) compared with 17% (49 of 
297) of those in usual care. Although smoking cessation 
as an outcome overlooks women identiﬁ ed as smokers 
at the end of pregnancy who were not classiﬁ ed as 
smokers at registration, it allows us to put the prenatal 
smoking eﬀ ects in the trial into context.11 These cessation 
rates are much larger than those identiﬁ ed for most 
prenatal counselling and education interventions for 
women who smoked at baseline, and in which cessation 
is biochemically validated (ie, 9–11%, calculated from 
studies reported in a review of the scientiﬁ c literature).11 
Thus, both usual care and FNP were comparatively 
successful, notwithstanding how much more needs to be 
done to reduce prenatal cigarette smoking. By contrast, 
neither FNP nor usual care prevented subsequent 
pregnancy within 24 months after delivery of the ﬁ rst 
child (66% in both groups). These high rates make me 
wonder whether this outcome has the same functional 
meaning in this sample as it does elsewhere.12
The two primary child outcomes selected for Robling 
and colleagues’ trial2 are not outcomes that FNP claims 
to aﬀ ect. There were no previous replicated eﬀ ects 
on birthweight or children’s accident and emergency 
department encounters as operationalised in this trial. 
It is noteworthy that this accident and emergency 
outcome combines all emergency encounters and 
hospital admissions into a single yes or no variable. 
This categorisation does not distinguish, for example, 
between a concerned parent taking a child with a 
possible ear infection to accident and emergency when 
GP care is unavailable, and a comatose child admitted for 
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abusive head trauma. The higher rate of an accident and 
emergency outcome encounter in the FNP group (81% vs 
77%) might represent heightened parental concern and 
raises questions about this variable’s meaning.
Two child outcomes of clear public health importance 
aﬀ ected in previous trials were not selected as primary 
outcomes. The ﬁ rst is language or cognitive development, 
which was measured objectively in earlier trials.3–5 Robling 
and colleagues’ study2 would have been strengthened 
had its designers identiﬁ ed language as a primary 
outcome and measured it directly. In view of previous 
replicated eﬀ ects, the signiﬁ cant intervention–control 
diﬀ erences in maternally reported language development 
(and language and cognitive development concerns) in 
this trial are promising: at the age of 24 months, children 
in the FNP group had mean Early Language Milestone 
percentile values of 60·8 (SD 31·4) versus 55·7 (SD 31·4) 
for children in the usual-care group; at age 18 months, 
language development concerns (children not meeting 
milestones) were present for 84 (17%) of 490 in the FNP 
group versus 110 (24%) of 455 for those in usual care; 
and at 24 months, cognitive development concerns 
were present for 46 (8%) of 569 children in the FNP 
group versus 66 (13%) of 522 for those in usual care. 
Both children in FNP and usual care exceeded the median 
normative values for age-matched children assessed with 
the Early Language Milestone; both groups were faring 
better than most children of their age.
The second outcome of importance is serious injury, 
often an indication of maltreatment in young children. 
Although more safeguarding was reported in FNP than 
in usual-care families, this is consistent with previous 
ﬁ ndings,13 and probably represents FNP nurses’ eﬀ orts 
to ensure children’s protection. In view of previous 
programme impact on maltreatment and length 
of hospital stay for injuries,3 a case can be made for 
examining serious injuries in such trials—an outcome 
much more consistent with previous eﬀ ects.
Those responsible for delivering FNP in the UK must 
now determine next steps. Continued assessment is 
essential as increased eﬀ ort is focused on mothers 
who need FNP the most, and intensiﬁ ed support is 
given to nurses tackling challenging behaviour, such 
as maternal smoking and pregnancy planning. The 
results of Robling and colleagues’ trial2 underscore why 
we cannot simply disseminate programmes without 
assessing them, and why, to accelerate construction 
of a solid early-intervention evidence base, we need to 
ensure that results and insights from previous studies 
are integrated thoroughly into the designs of new ones.
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